OligoTune
Develops RNA-based immunotherapies that reprogram the tumour microenvironment to target treatment-resistant tumours.
Designs patient-centered therapeutic approaches for cancer patients with resistant tumours.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
